ArticleBlood2017

Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia.

Karina A Kruth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.